JP2019529571A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019529571A5 JP2019529571A5 JP2019538580A JP2019538580A JP2019529571A5 JP 2019529571 A5 JP2019529571 A5 JP 2019529571A5 JP 2019538580 A JP2019538580 A JP 2019538580A JP 2019538580 A JP2019538580 A JP 2019538580A JP 2019529571 A5 JP2019529571 A5 JP 2019529571A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- functional rna
- rna molecule
- composition
- small molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662403595P | 2016-10-03 | 2016-10-03 | |
| US62/403,595 | 2016-10-03 | ||
| PCT/US2017/054884 WO2018067526A1 (en) | 2016-10-03 | 2017-10-03 | Functional rna and small-molecule drug therapeutic complexes and nanoparticle delivery vehicles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019529571A JP2019529571A (ja) | 2019-10-17 |
| JP2019529571A5 true JP2019529571A5 (https=) | 2020-11-12 |
Family
ID=61831202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019538580A Pending JP2019529571A (ja) | 2016-10-03 | 2017-10-03 | 機能性ｒｎａと小分子薬の治療用複合体、およびナノ粒子送達ビヒクル |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20190240344A1 (https=) |
| EP (1) | EP3518939A4 (https=) |
| JP (1) | JP2019529571A (https=) |
| CN (1) | CN109890393A (https=) |
| AU (1) | AU2017339456A1 (https=) |
| CA (1) | CA3039040A1 (https=) |
| WO (1) | WO2018067526A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010085665A2 (en) | 2009-01-23 | 2010-07-29 | Cedars-Sinai Medical Center | Targeted delivery system |
| JP6608370B2 (ja) | 2014-01-17 | 2019-11-20 | シーダーズ―シナイ メディカル センター | 受容体標的化構築物およびその使用 |
| CA3087325A1 (en) * | 2018-01-02 | 2019-07-11 | Cedars-Sinai Medical Center | Nanoparticles for the targeted delivery of therapeutic polypeptides |
| CN109432430B (zh) * | 2018-11-22 | 2021-12-17 | 华南理工大学 | 一种siRNA和抗癌药物疏水性复合物及其制备方法与应用 |
| JP7698252B2 (ja) * | 2019-09-06 | 2025-06-25 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 治療薬の核酸媒介性送達 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4813712B2 (ja) * | 1999-08-09 | 2011-11-09 | ザ ジェネラル ホスピタル コーポレーション | 薬物−担体複合体およびその使用方法 |
| CA2881743A1 (en) * | 2002-09-25 | 2004-04-08 | University Of Massachusetts | In vivo gene silencing by chemically modified and stable sirna |
| WO2009009441A2 (en) * | 2007-07-06 | 2009-01-15 | Cedars-Sinai Medical Center | Self-assembling complex for targeting chemical agents to cells |
| JP5252618B2 (ja) * | 2007-10-26 | 2013-07-31 | 独立行政法人産業技術総合研究所 | ＲＮＡ干渉効果が高い芳香環修飾ｓｉＲＮＡ |
| WO2010085665A2 (en) * | 2009-01-23 | 2010-07-29 | Cedars-Sinai Medical Center | Targeted delivery system |
| JP6608370B2 (ja) * | 2014-01-17 | 2019-11-20 | シーダーズ―シナイ メディカル センター | 受容体標的化構築物およびその使用 |
| BR112018074304A2 (pt) * | 2016-05-27 | 2019-10-01 | Cedars Sinai Medical Center | composições de nanopartículas, kit e método para tratar um indivíduo com câncer resistente a fármacos |
-
2017
- 2017-10-03 EP EP17858997.4A patent/EP3518939A4/en not_active Withdrawn
- 2017-10-03 CN CN201780061209.0A patent/CN109890393A/zh active Pending
- 2017-10-03 CA CA3039040A patent/CA3039040A1/en not_active Abandoned
- 2017-10-03 JP JP2019538580A patent/JP2019529571A/ja active Pending
- 2017-10-03 AU AU2017339456A patent/AU2017339456A1/en not_active Abandoned
- 2017-10-03 US US16/338,909 patent/US20190240344A1/en not_active Abandoned
- 2017-10-03 WO PCT/US2017/054884 patent/WO2018067526A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019529571A5 (https=) | ||
| Mo et al. | ATP-responsive DNA-graphene hybrid nanoaggregates for anticancer drug delivery | |
| US11242532B2 (en) | Self-assembled 3D RNA cage nanoparticles | |
| Taghdisi et al. | Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes | |
| Zhao et al. | Magnesium-stabilized multifunctional DNA nanoparticles for tumor-targeted and pH-responsive drug delivery | |
| Tyagi et al. | Exploiting nanotechnology for the development of microRNA-based cancer therapeutics | |
| CN110573184B (zh) | Rna纳米结构，其制备方法和用途 | |
| Yao et al. | Targeted therapy of colon cancer by aptamer-guided holliday junctions loaded with doxorubicin | |
| JP2019506862A5 (https=) | ||
| JP2018512060A5 (https=) | ||
| JP2015516989A5 (https=) | ||
| EP2700414B1 (en) | Self-gelatinizable nucleic acid | |
| Luo et al. | Framework nucleic acid-based multifunctional tumor theranostic nanosystem for miRNA fluorescence imaging and chemo/gene therapy | |
| JP2017514800A5 (https=) | ||
| Manikkath et al. | Nanoparticulate strategies for the delivery of miRNA mimics and inhibitors in anticancer therapy and its potential utility in oral submucous fibrosis | |
| Ngamcherdtrakul et al. | Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment | |
| EP3600341A1 (en) | Gemcitabine derivatives for cancer therapy | |
| JP2019517477A5 (https=) | ||
| Song et al. | Self‐Assembled DNA Nanostructures for Biomedical Applications | |
| Almalki et al. | Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics | |
| CN109890393A (zh) | 功能rna和小分子药物治疗性复合物和纳米颗粒递送媒介 | |
| US20190209695A1 (en) | Pharmaceutical Compositions for High-Capacity Targeted Delivery | |
| WO2017162185A1 (zh) | 对非小细胞肺癌具有抑制作用的核糖核酸适配体及包含其的药物组合物 | |
| CN105814202B (zh) | Notch1特异性sirna分子 | |
| JP2016533190A5 (https=) |